Interview w/ Eyal Barad, Cannabics Pharmaceuticals Inc. CEO on Cannabis Treating Colorectal Cancer Age of Weed + Psychedelics with Marc Eden

Marc Eden interviews Eyal Barad, Co-founder and CEO of Cannabics Pharmaceuticals, Inc (CNBX) about their cannabis biotech company and groundbreaking cannabinoid based anti-tumor drug for treating colorectal cancer. Cannabics Pharmaceuticals is based in Maryland in the United States, however their cannabis medicine R&D is located in Israel. Cannabics Pharmaceuticals Inc. has the world’s first cannabinoid based anti-tumor drug candidate for treating colorectal cancer based on their novel and proprietary IP. Other topics discussed include Cannabics milestones, cannabinoids, terpenes, cannabis legalization across the world, and home growing. Listen to hear Eyal Barad’s take on cannabis and cancer, cannabis as medicine, and even on who is leading Europe in cannabis policy. Eyal also weighs in on the opportunity for home growing and cannabis medicine.

---

Send in a voice message: https://podcasters.spotify.com/pod/show/green-carpet-growing/message
Support this podcast: https://podcasters.spotify.com/pod/show/green-carpet-growing/support